Partnering is a key component of Priavoid´s strategy
We are developing alliances with leading pharmaceutical and biotech companies around the world and are active in talking to potential new partners on our promising pipeline of novel CNS compounds.
We are developing alliances with leading pharmaceutical and biotech companies around the world and are active in talking to potential new partners on our promising pipeline of novel CNS compounds.
Cookie Preference
Please select an option. You can find more information about the consequences of your choice at Help.
Select an option to continue
Your selection was saved!
Help
Help
To continue, you must make a cookie selection. Below is an explanation of the different options and their meaning.
You can change your cookie setting here anytime: Privacy Policy. Legal Notice
Back